Systematic Review

Published on 28 May 2020

Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Rong Li
Minqing Liang
Xiao Liang
Lu Yang
Min Su
Keng Po Lai

Frontiers in Oncology

doi 10.3389/fonc.2020.00868

7,833 views
15 citations

Review

Published on 19 May 2020

Electrolyte Disorders Induced by Antineoplastic Drugs

in Pharmacology of Anti-Cancer Drugs

Ignazio Verzicco
Giuseppe Regolisti
Federico Quaini
Pietro Bocchi
Irene Brusasco
Massimiliano Ferrari
Giovanni Passeri
Valentina Cannone
Pietro Coghi
Enrico Fiaccadori

Frontiers in Oncology

doi 10.3389/fonc.2020.00779

42,782 views
54 citations

Original Research

Published on 14 May 2020

Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma

in Pharmacology of Anti-Cancer Drugs

Sandhya Chipurupalli
Raja Ganesan
S. P. Dhanabal
M. Suresh Kumar
Nirmal Robinson

Frontiers in Oncology

doi 10.3389/fonc.2020.00758

9,008 views
22 citations

Original Research

Published on 12 May 2020

Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro

in Pharmacology of Anti-Cancer Drugs

Kyeong Seok Kim
Chunxue Jiang
Ji Young Kim
Jae Hyeon Park
Hae Ri Kim
Su Hyun Lee
Hyung Sik Kim
Sungpil Yoon

Frontiers in Oncology

doi 10.3389/fonc.2020.00696

3,809 views
12 citations

Original Research

Published on 12 May 2020

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Zhuo-Xun Wu
Zheng Peng
Yuqi Yang
Jing-Quan Wang
Qiu-Xu Teng
Zi-Ning Lei
Yi-Ge Fu
Ketankumar Patel
Lili Liu
Lizhu Lin

Frontiers in Oncology

doi 10.3389/fonc.2020.00674

6,570 views
23 citations

Original Research

Published on 12 May 2020

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

in Pharmacology of Anti-Cancer Drugs

Yuqi Yang
Ning Ji
Qiu-Xu Teng
Chao-Yun Cai
Jing-Quan Wang
Zhuo-Xun Wu
Zi-Ning Lei
Sabrina Lusvarghi
Suresh V. Ambudkar
Zhe-Sheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.00700

6,705 views
32 citations

Review

Published on 07 May 2020

Extracellular Vesicles in Renal Cell Carcinoma: Multifaceted Roles and Potential Applications Identified by Experimental and Computational Methods

in Pharmacology of Anti-Cancer Drugs

Zhiyuan Qin
Qingwen Xu
Haihong Hu
Lushan Yu
Su Zeng

Frontiers in Oncology

doi 10.3389/fonc.2020.00724

6,824 views
22 citations

Original Research

Published on 06 May 2020

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome

in Pharmacology of Anti-Cancer Drugs

Guoliang Dai
Zhitao Jiang
Bingting Sun
Chao Liu
Qinghai Meng
Kang Ding
Wen Jing
Wenzheng Ju

Frontiers in Oncology

doi 10.3389/fonc.2020.00721

5,843 views
36 citations

Original Research

Published on 05 May 2020

Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for in vivo Improvement of Synergistic Chemotherapy in Esophageal Cancer

in Pharmacology of Anti-Cancer Drugs

Wenhua Zhan
Hanrui Li
Yingying Guo
Getao Du
Yayan Wu
Dexin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.00622

4,096 views
14 citations

Original Research

Published on 28 Apr 2020

Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study

in Pharmacology of Anti-Cancer Drugs

Massimiliano Berretta
Luca Rinaldi
Rosaria Taibi
Paolo Tralongo
Alberto Fulvi
Vincenzo Montesarchio
Giordano Madeddu
Paolo Magistri
Sabrina Bimonte
Marco Trovò

Frontiers in Oncology

doi 10.3389/fonc.2020.00594

12,988 views
57 citations

Original Research

Published on 23 Apr 2020

Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy

in Pharmacology of Anti-Cancer Drugs

Mathias Dahlmann
Rebecca Werner
Benedikt Kortüm
Dennis Kobelt
Wolfgang Walther
Ulrike Stein

Frontiers in Oncology

doi 10.3389/fonc.2020.00599

4,379 views
15 citations

Case Report

Published on 23 Apr 2020

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy

in Pharmacology of Anti-Cancer Drugs

Anna-Sophia Kattner
Ernst Holler
Wolfgang Herr
Albrecht Reichle
Daniel Wolff
Daniel Heudobler

Frontiers in Oncology

doi 10.3389/fonc.2020.00443

8,143 views
7 citations

Original Research

Published on 22 Apr 2020

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST

in Pharmacology of Anti-Cancer Drugs

Annalisa Astolfi
Valentina Indio
Margherita Nannini
Maristella Saponara
Angela Schipani
Antonio De Leo
Annalisa Altimari
Bruno Vincenzi
Danila Comandini
Giovanni Grignani

Frontiers in Oncology

doi 10.3389/fonc.2020.00504

5,229 views
21 citations

Retraction

Published on 20 Apr 2020

Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

in Pharmacology of Anti-Cancer Drugs

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2020.00714

5,133 views

Case Report

Published on 09 Apr 2020

Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia

in Pharmacology of Anti-Cancer Drugs

Andra Marcu
Andrei Colita
Letitia Elena Radu
Cristina Georgiana Jercan
Ana Maria Bica
Minodora Asan
Daniel Coriu
Alina Daniela Tanase
Carmen C. Diaconu
Cristina Mambet

Frontiers in Oncology

doi 10.3389/fonc.2020.00484

5,058 views
9 citations

Case Report

Published on 08 Apr 2020

Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant 7 Expression in Circulating Tumor Cells: A Case Report

in Pharmacology of Anti-Cancer Drugs

Naoya Nagaya
Mayuko Kanayama
Masayoshi Nagata
Shigeo Horie

Frontiers in Oncology

doi 10.3389/fonc.2020.00495

3,914 views
6 citations

Navigation group

Articles

Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis

Electrolyte Disorders Induced by Antineoplastic Drugs

Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma

Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

Extracellular Vesicles in Renal Cell Carcinoma: Multifaceted Roles and Potential Applications Identified by Experimental and Computational Methods

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome

Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for in vivo Improvement of Synergistic Chemotherapy in Esophageal Cancer

Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study

Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST

Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia

Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant 7 Expression in Circulating Tumor Cells: A Case Report